Tip 2 Diyabette D Vitamini Düşüklüğünün Yadsınamaz Etkisi
Özet
Diyabet, insülin eksikliğiyle ortaya çıkan antik çağlardan beri bilinen kronik bir hastalıktır ve küresel ölçekte milyonlarca insanı etkileyen bir epidemi halini almıştır. Epideminin artışında obezite, hareketsiz yaşam ve stres gibi klasik faktörlerin yanı sıra D vitamini düşüklüğü de önemli bir tetikleyici olarak kabul edilmektedir. D vitamini, sentezi ve vücutta aktifleşmesi süreçleriyle kalsiyum dengesini yöneten ve beta hücre fonksiyonları ile insülin direnci üzerinde doğrudan veya dolaylı etkileri olan bir prehormondur. Laboratuvar ortamında hayvanlar üzerinde yürütülen deneysel araştırmalar, D vitamini yetersizliğinin insülin duyarlılığını azalttığını ve takviyenin kan şekeri regülasyonuna olumlu katkı sağladığını tutarlı bir şekilde göstermektedir. Buna karşın, insanlar üzerinde yapılan prospektif izlem ve klinik müdahale çalışmalarında D vitamini takviyesinin insülin direnci, glukoz toleransı ve glisemik kontrol üzerindeki net faydalarına ilişkin sonuçlar değişkenlik göstermekte; bazı çalışmalar iyileşme bildirirken bazıları ise anlamlı bir etki saptayamamaktadır. Bu klinik belirsizliklerin aşılması, tedavinin başlama zamanı ile süresinin standardize edilmesi ve D vitamininin uzun vadedeki etkilerinin tam olarak anlaşılabilmesi için gelecekte diyabet tanılı, çok daha fazla katılımcının yer aldığı geniş ölçekli ve uzun süreli klinik çalışmalara ihtiyaç duyulmaktadır.
Diabetes is a chronic disease known since ancient times resulting from insulin deficiency and has become a global epidemic affecting millions of people. In addition to classic factors such as obesity, sedentary lifestyle, and stress, vitamin D deficiency is also recognized as an important trigger in the rise of this epidemic. Vitamin D is a prehormone that regulates calcium balance through its synthesis and activation processes in the body, exerting direct or indirect effects on beta-cell functions and insulin resistance. Experimental research conducted on animals in laboratory settings consistently demonstrates that vitamin D deficiency decreases insulin sensitivity and that supplementation contributes positively to blood sugar regulation. In contrast, results from prospective follow-up and clinical intervention studies in humans regarding the definitive benefits of vitamin D supplementation on insulin resistance, glucose tolerance, and glycemic control remain variable, with some studies reporting improvements while others detect no significant effect. To resolve these clinical ambiguities, standardize treatment initiation and duration, and fully comprehend the long-term effects of vitamin D, extensive and long-term future clinical trials involving a substantially larger number of participants diagnosed with diabetes are required.
Referanslar
Şeker hastalığının 3500 yıllık ilginç tarihi hikayesi. retrieved Nov. 3, 2021, from ‘https://ungo.com.tr/2019/08/seker-hastaliginin-3500-yillik-tarihi-hikayesi/’
Correia LG. President Ernesto Roma Foundation. A History of Diabetes, retrieved Nov. 3, 2021, from ‘https://www.diabetes.org/resources/timeline’
World Health Organization. Diabetes, retrieved Nov. 3, 2021, from ‘https://www.who.int/healthtopics/diabetes’
International Diabetes Federation. Diabetes now affects one in 10 adults worldwide, retrieved Nov. 8, 2021, from ‘https://www.idf.org/news/240:diabetes-now-affects-one-in-10-adults-worldwide.html’
Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169-80.
TUİK. Adrese Dayalı Nüfus Kayıt Sistemi 2020 Verileri, retrieved Feb 4, 2021 from 'https://biruni.tuik.gov.tr/medas/?kn=95&locale=tr'
IDF. Diabetes Atlas. 9. Ed., retrieved Nov. 3, 2021, from ‘https://www.idf.org/e-library/epidemiologyresearch/diabetes-atlas/159-idf-diabetes-atlas-ninth-edition-2019.html?layout=hcopy’
Sağlık Bakanlığı, Sağlığın Geliştirilmesi Genel Müdürlüğü. Dünya Diyabet Günü 2020, retrieved Nov. 3, 2021, from ‘https://sggm.saglik.gov.tr/TR-76887/dunya-diyabet-gunu-2020.html’
World Health Organization. Access to Diabetes Care, retrieved Nov. 3, 2021, from ‘http://worlddiabetesday.org/about/’
Pilz S, Zittermann A, Trummer C, Schwetz V, Lerchbaum E, Keppel M, Grübler M, Maerz W, Pandis M. Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect 2019;8(2): R27-R43. doi: 10.1530/EC-18-0432.
Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104:787-94.
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53:693-700.
Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. P Plasma 25- hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 2010; 33:2021-3.
Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106:963-8.
Gagnon C, Lu ZX, Magliano DJ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011; 34:1133-8.
Grimnes G, Emaus N, Joakimsen RM, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 2010; 27:1107-15.
Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 2009; 22:82-92.
Billaudel BJ, Delbancut AP, Sutter BC, Faure AG. Stimulatory effect of 1,25- dihydroxyvitamin D3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats. Steroids 1993; 58:335-41.
Billaudel BJ, Faure AG, Sutter BC. Effect of 1,25 dihydroxyvitamin D3 on isolated islets from vitamin D3-deprived rats. Am J Physiol 1990; 258:643-8.
Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005; 48:1247-57.
Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008; 57:183-91.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89:552-72.
Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond) 2012; 36:387-96.
Kawashima H, Castro A. Effect of 1 alpha-hydroxyvitamin D3 on the glucose and calcium metabolism in genetic obese mice. Res Commun Chem Pathol Pharmacol 1981; 33:155-61.
de Souza Santos R, Vianna LM. Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin Chim Acta 2005; 358:146-50.
Ceylan-Isik A, Hünkâr T, Aşan E, et al. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats. J Pharm Pharmacol 2007; 59: 1629-41.
Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29:650-6.
de Boer IH, Tinker LF, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008; 31:701-7.
Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebocontrolled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26:19-27.
Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94:486-94.
Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30:980-6.
Parekh D, Sarathi V, Shivane VK , et al. Pilot study to evaluate the effect of shortterm improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract 2010; 16:600-8.
Orwoll E, Riddle M, Prince M. E Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994; 59:1083-7.
Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57:258-61.
Nikooyeh B, Neyestani TR, Farvid M , et al. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011; 93:764-71.
Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-14.
